Does metformin affect ovarian morphology in patients with polycystic ovary syndrome? A retrospective cross-sectional preliminary analysis
Explore this paper's citation graph
Summary
PCOS patients under metformin administration demonstrate a change in ovarian morphology closely related to ovulatory response, whereas a significant reduction in ovarian dimension was observed in the PCOS ovulatory group only.
- Type
- article
- Published
- 2009-05-31
- Cited by
- 13
- References
- 31
- Access
- Open access
- OpenAlex
- https://openalex.org/W19480717
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:7908803
Keywords
Humanities, Art, Spanish literature
References
- Polycystic ovaries in Hirsute women with normal menses.
- Standards for ovarian volume in childhood and puberty.
- Polycystic ovary syndrome.
- Metformin effects on ovarian ultrasound appearance and steroidogenic function in normal-weight normoinsulinemic women with polycystic ovary syndrome: a randomized double-blind placebo-controlled clinical trial.
- Glucose-to-insulin ratio rather than sex hormone-binding globulin and adiponectin levels is the best predictor of insulin resistance in nonobese women with polycystic ovary syndrome.
- Polycystic ovarian morphology with regular ovulatory cycles: insights into the pathophysiology of polycystic ovarian syndrome.
- Polycystic ovaries in childhood: a common finding in daughters of PCOS patients. A pilot study.
- Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism.
- Effects of metformin and clomiphene citrate on ovarian vascularity in patients with polycystic ovary syndrome.
- Polycystic ovaries in nonobese adolescents and young women with ovarian androgen excess: relation to prenatal growth.
- Efficacy predictors for metformin and clomiphene citrate treatment in anovulatory infertile patients with polycystic ovary syndrome.
- Clinical assessment of body hair growth in women.
- Normal ovulatory women with polycystic ovaries have hyperandrogenic pituitary-ovarian responses to gonadotropin-releasing hormone-agonist testing.
- Ovarian size and blood flow in women with polycystic ovary syndrome and their correlations with endocrine parameters.
- Ultrasound assessment of the polycystic ovary: international consensus definitions.
- Subjects with polycystic ovaries without hyperandrogenaemia exhibit similar disturbances in insulin and lipid profiles as those with polycystic ovary syndrome.
- Polycystic ovarian morphology in normal women does not predict the development of polycystic ovary syndrome.
- Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis.
- Acute effects of metformin therapy include improvement of insulin resistance and ovarian morphology.
- Insulin sensitivity after metformin suspension in normal-weight women with polycystic ovary syndrome.
Cited by
- Physical activity before IVF and ICSI cycles in infertile obese women: an observational cohort study.
- Effects of metformin in women with polycystic ovary syndrome treated with gonadotrophins for in vitro fertilisation and intracytoplasmic sperm injection cycles: a systematic review and meta‐analysis of randomised controlled trials
- Grid analysis improves reliability in follicle counts made by ultrasonography in women with polycystic ovary syndrome.
- Prenatal androgenization of female mice programs an increase in firing activity of gonadotropin-releasing hormone (GnRH) neurons that is reversed by metformin treatment in adulthood.
- Metformin and gonadotropins for ovulation induction in patients with polycystic ovary syndrome: a systematic review with meta-analysis of randomized controlled trials
- Serum and follicular anti-Mullerian hormone levels in women with polycystic ovary syndrome (PCOS) under metformin
- Metformin reduces risk of ovarian hyperstimulation syndrome in patients with polycystic ovary syndrome during gonadotropin-stimulated in vitro fertilization cycles: a randomized, controlled trial.
- 220. Stellungnahme. Stellungnahme zum Einsatz von Metformin vor und während der Schwangerschaft bei Frauen mit PCOS und Kinderwunsch
- 3 to 5 Years Later: Long-term Effects of Prophylactic Bilateral Salpingectomy on Ovarian Function.
- ANALYSIS OF HOMA-IR, FOLLICLE SIZE, AND ESTRADIOL AFTER COMBINATION THERAPY OF METFORMIN AND CLOMIPHENE CITRATE IN POLYCYSTIC OVARY SYNDROME’S PATIENT
- The resting metabolic rate in women with polycystic ovary syndrome and its relation to the hormonal milieu, insulin metabolism, and body fat distribution: a cohort study
- Effect of metformin on clinical and biochemical hyperandrogenism in adolescent girls with type 1 diabetes
- Dehydroepiandrosterone(DHEA) combining Metformin – Adjuvant Agents for Ovulation Induction in Poor Ovarian Responders
Related papers
No related papers recorded.